Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Simplification of F-Form of PCPNDT Act: Doctor’s Demand
In Maharashtra doctors demanding for simplification of F-Form of Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act. Filling-up of F-Form a tedious and lengthy job. F-Form is an important document for maintaining the record in case of prenatal diagnostic test/procedure by genetic clinic/ultrasound clinic and imaging centre.
- Read more about Bosch introduce GranuLean
Bosch Packaging _Technology, one of the leading suppliers introduce the new granulation unit, GranuLean at Achema 2015 to be held in Germany from June 15 to 19, 2015. It ranges from filling, processing, and packaging technology for piece goods and bulk items in the food, pharmaceutical, and confectionery sectors as well as for health and hygiene products.
- Read more about Paracetamol may Blunt Positive Emotions: Study
Researchers studying the commonly used pain reliever acetaminophen or paracetamol have found that it has a previously unknown side effect: it blunts positive emotions. In the study, participants who took acetaminophen reported less strong emotions when they saw both very pleasant and very disturbing photos, when compared to those who took placebos.
- Read more about Biogen & AbbVie want approval by US FDA marketing for Zinbryta to treat multiple sclerosis
The US Food and Drug Administration (FDA) has accepted request by Biogen and AbbVie's Biologics License Application (BLA) for marketing approval of Zinbryta (daclizumab high-yield process) for the treatment of multiple sclerosis (MS).
Ella Foundation of Bharat Biotech has successfully tested a preliminary vaccine for Ebola on mice. Ella Foundation has been trying to discover a suitable vaccine to check the deadly viral disease that shook the world recently. Vaccine from adenovirus and glycoprotein was tested on mice and the good results were found to be for developing a full-fledged vaccine. Adenoviruses are accountable for respiratory infections, gastroenteritis, cystitis, and primary pneumonia in humans, and are used as a clear target to understand the human immunity characteristics in laboratory. However, the efficacy of the vaccine will be evaluated by the results seen in human trials.

Ebola, previously known as Ebola hemorrhagic fever, is a rare and deadly disease caused by infection with one of the Ebola virus strain. Ebola is a multi-organ infecting disease. The virus could spread fast through human touch. Particularly India needs to be vigilant in containing this disease. Having understood the gravity of the situation across the world due to this disease the efforts of Bharat Biotech and its foundation are hailed all over. It has not yet hit India. The worst hit part of the world is Africa.

Other major companies that are working to provide a fool proof vaccine solution to Ebola in the world are GlaxoSmitKline, Johnson & Johnson, Merck and Novavax. All these companies combined have invested an amount of approximately 500 million towards research and development of this vaccine.

<< Pharma News

Subscribe to PharmaTutor News Alerts by Email >>
- Read more about Mutated Ebola Virus has not become Deadlier: Study
Despite mutating, the ebola virus has not evolved to become deadlier since the first outbreak 40 years ago, scientists say. The findings suggest that the much higher death toll during the current outbreak, with the figure at nearly 10,500, is not due to mutations making the virus more deadly or more virulent.
- Read more about Single- Dose Ebola Vaccine Developed
Researchers have developed a quick-acting Ebola vaccine that is both safe and effective with a single dose against the strain of the virus that killed thousands of people in West Africa last year. “These findings may pave the way for the identification and manufacture of safer, single dose, high efficiency vaccines to combat current and future Ebola outbreaks,” said Thomas Geisbert, from the University of Texas Medical Branch at Galveston.
- Read more about Teva provides additional detail on proposed acquisition of Mylan
(Business Wire India); Teva Pharmaceutical Industries Ltd. has announced that an updated investor presentation in connection with its proposed combination with Mylan N.V. is available on the Investor Relations section of the Company’s website and will be filed with the Securities and Exchange Commission (“SEC”).
6 May 2015

Breast cancer vaccines and silicon microparticles together may work better

The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles, report scientists from Houston Methodist and two other institutions in an upcoming Cell Reports (early online).
- Read more about EU received marketing approval for Sanofi Toujeo to treat diabetes in adults
The European Commission has granted marketing authorization in Europe for Sanofi's Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL), a next-generation basal insulin for the treatment of type 1 and type 2 diabetes mellitus in adults. Its significant milestone for Sanofi. This gives people with diabetes and their physicians a new option to manage their condition.